The key to managing side effects is proper dose escalation
You can speak to your dietitian about what supplements are right for you
Semaglutide acts on the pancreas to reduce both pre- and post-prandial blood glucose concentrations in a glucose-dependent manner primarily by increasing insulin production and inhibiting the secretion of glucagon
In June 2024, Teva Pharmaceuticals announced the launch of the first generic version of a GLP-1 receptor agonist in the United States, specifically liraglutide 1.8 mg
When lifestyle factors are the bottleneck If you are consuming excess calories despite appetite suppression (eating through fullness signals), not exercising, sleeping poorly, or under chronic stress, a receptor reset will not fix these issues
That continued oversight is what makes this a genuine medical program rather than just a prescription